Notably, anti-IL-8 therapy has been shown to effectively suppress tumor colonization, growth, and bone destruction, highlighting IL-8 as a potential therapeutic target in bone-metastatic breast cancer [149]. This evidence concerns the gene CXCL8 and neoplasm.